Kura Oncology, Inc. Common Stock Shares Outstanding

• Kura Oncology, Inc. showed an increase of +12.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Kura Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Kura Oncology, Inc.'s Common Stock Shares Outstanding has grown by 1,657.1%.
• Historical annual values: Fiscal year 2025: 87.86 million shares | Fiscal year 2024: 78.23 million shares | Fiscal year 2023: 74.35 million shares | Fiscal year 2022: 68.31 million shares | Fiscal year 2021: 66.57 million shares | Fiscal year 2020: 66.19 million shares | Fiscal year 2019: 45.38 million shares | Fiscal year 2018: 38.15 million shares | Fiscal year 2017: 29.42 million shares | Fiscal year 2016: 19.35 million shares | Fiscal year 2015: 18.14 million shares | Fiscal year 2014: 411,000 shares | Fiscal year 2013: 5.00 million shares | Fiscal year 2012: 5.00 million shares | Fiscal year 2011: 5.00 million shares | Fiscal year 2010: 5.00 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026